These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24576319)

  • 1. Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.
    Garibay-Cerdenares OL; Hernández-Ramírez VI; Osorio-Trujillo JC; Hernández-Ortíz M; Gallardo-Rincón D; Cantú de León D; Encarnación-Guevara S; Villegas-Pineda JC; Talamás-Rohana P
    J Ovarian Res; 2014 Feb; 7():27. PubMed ID: 24576319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.
    Villegas-Pineda JC; Garibay-Cerdenares OL; Hernández-Ramírez VI; Gallardo-Rincón D; Cantú de León D; Pérez-Montiel-Gómez MD; Talamás-Rohana P
    Pathol Res Pract; 2015 Dec; 211(12):973-81. PubMed ID: 26549463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer.
    Ahmed N; Barker G; Oliva KT; Hoffmann P; Riley C; Reeve S; Smith AI; Kemp BE; Quinn MA; Rice GE
    Br J Cancer; 2004 Jul; 91(1):129-40. PubMed ID: 15199385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants.
    Menzin AW; Loret de Mola JR; Bilker WB; Wheeler JE; Rubin SC; Feinberg RF
    Cancer; 1998 Jan; 82(1):152-8. PubMed ID: 9428492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
    Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
    Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
    Matsumoto H; Shinzaki S; Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Kanke F; Satomura S; Kumada T; Miyoshi E
    Clin Chem Lab Med; 2010 Apr; 48(4):505-12. PubMed ID: 20128732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures.
    Miyoshi E; Nakano M
    Proteomics; 2008 Aug; 8(16):3257-62. PubMed ID: 18646007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
    Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
    J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
    Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
    Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation.
    Okuyama N; Ide Y; Nakano M; Nakagawa T; Yamanaka K; Moriwaki K; Murata K; Ohigashi H; Yokoyama S; Eguchi H; Ishikawa O; Ito T; Kato M; Kasahara A; Kawano S; Gu J; Taniguchi N; Miyoshi E
    Int J Cancer; 2006 Jun; 118(11):2803-8. PubMed ID: 16385567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF].
    Zhao Q; Duan W; Wu YM; Qian XH; Deng XH
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):754-8. PubMed ID: 19173805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides.
    Miyamoto S; Ruhaak LR; Stroble C; Salemi MR; Phinney B; Lebrilla CB; Leiserowitz GS
    J Proteome Res; 2016 Sep; 15(9):3358-76. PubMed ID: 27500424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology.
    Chow SN; Chen RJ; Chen CH; Chang TC; Chen LC; Lee WJ; Shen J; Chow LP
    Eur J Gynaecol Oncol; 2010; 31(1):55-62. PubMed ID: 20349782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer.
    Thompson S; Cantwell BM; Matta KL; Turner GA
    Cancer Lett; 1992 Aug; 65(2):115-21. PubMed ID: 1511415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.
    Lin Z; Simeone DM; Anderson MA; Brand RE; Xie X; Shedden KA; Ruffin MT; Lubman DM
    J Proteome Res; 2011 May; 10(5):2602-11. PubMed ID: 21417406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and analysis of alpha1,6-fucosylated proteins in human normal liver tissues by a target glycoproteomic approach.
    Dai Z; Fan J; Liu Y; Zhou J; Bai D; Tan C; Guo K; Zhang Y; Zhao Y; Yang P
    Electrophoresis; 2007 Dec; 28(23):4382-91. PubMed ID: 18041034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.
    Huang H; Li Y; Liu J; Zheng M; Feng Y; Hu K; Huang Y; Huang Q
    PLoS One; 2012; 7(12):e51256. PubMed ID: 23251472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.